Incyte (INCY) Total Liabilities (2010 - 2026)
Incyte (INCY) posted Total Liabilities of $1.7 billion for Q1 2026, down 4.15% on a QoQ basis from $1.8 billion in Q4 2025, and down 17.56% year-over-year from $2.1 billion in Q1 2025.
Incyte (INCY) Total Liabilities (2010 - 2026) Analysis & Trends
Incyte's Total Liabilities history runs 17 years deep, the most recent figure standing at $1.7 billion for Q1 2026.
- Quarterly Total Liabilities fell 17.56% year-over-year to $1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (down 17.56% YoY) and the FY2025 annual result came in at $1.8 billion, down 10.33% from the prior year.
- Total Liabilities was $1.7 billion for Q1 2026 at Incyte, down from $1.8 billion in the prior quarter.
- Across five years, Total Liabilities topped out at $2.1 billion in Q1 2025 and bottomed at $1.2 billion in Q1 2022.
- A 5-year average of $1.6 billion and a median of $1.7 billion in 2025 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2024 — Total Liabilities soared 30.43% — and 2026, when it dropped 17.56%.
- Incyte's Total Liabilities stood at $1.5 billion in 2022, then grew by 8.25% to $1.6 billion in 2023, then advanced by 25.4% to $2.0 billion in 2024, then fell by 10.33% to $1.8 billion in 2025, then fell by 4.15% to $1.7 billion in 2026.
- Business Quant data shows INCY's Total Liabilities at $1.7 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 177.22 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 19.51 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 3.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 753.82 Mn |
| 10 | Incyte | 23.47 Bn | 19.46 Bn | 1.17 Bn | 1.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.72 Bn |
| Dec 31, 2025 | 1.79 Bn |
| Sep 30, 2025 | 1.68 Bn |
| Jun 30, 2025 | 1.65 Bn |
| Mar 31, 2025 | 2.08 Bn |
| Dec 31, 2024 | 2.00 Bn |
| Sep 30, 2024 | 1.84 Bn |
| Jun 30, 2024 | 1.66 Bn |
| Mar 31, 2024 | 1.74 Bn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.46 Bn |
| Jun 30, 2023 | 1.47 Bn |
| Mar 31, 2023 | 1.34 Bn |
| Dec 31, 2022 | 1.47 Bn |
| Sep 30, 2022 | 1.28 Bn |
| Jun 30, 2022 | 1.23 Bn |
| Mar 31, 2022 | 1.19 Bn |
| Dec 31, 2021 | 1.16 Bn |
| Sep 30, 2021 | 1.05 Bn |
| Jun 30, 2021 | 968.76 Mn |